Targeting extracellular pyrophosphates underpins the high selectivity of nisin
Open Access
- 1 December 2004
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 18 (15) , 1862-1869
- https://doi.org/10.1096/fj.04-2358com
Abstract
The spread of infectious diseases and the increase in antibiotic resistance represent a life-threatening global development that calls for new approaches to control microorganisms. Of all potential targets, the essential and unique pathway of bacterial cell wall synthesis, targeted by the first known antibiotic penicillin, remains a perfect candidate for the development of new antibiotics. Here we show that the lantibi-otic nisin exercises its antibacterial action by targeting peptidoglycan intermediates’ extracellular pyrophosphate, unique to bacterial cell wall precursors. We show that nisin sequesters cell wall precursors found in the outer leaflet of bacterial plasma membranes, Lipid II and undecaprenyl pyrophosphate, into stable complexes. We propose a model of antibacterial action for nisin in which the terminal amino group of Ile1 targets the pyrophosphate groups of the bacterial cell wall precursors, where it docks via a hydrogen bond. The pyrophosphate moiety, a highly conserved chemical group different from the L-Lys-D-Ala-D-Ala docking motif for vancomycin, has no biochemical analogs with comparable properties and is unlikely to be susceptible to bacterial adaptations akin to those responsible for resistance to penicillins and vancomycin.—Bonev, B. B., Breukink, E., Swiezewska, E., de Kruijff, B., Watts, A. Targeting extracellular pyrophosphates underpins the high selectivity of nisin. FASEB J. 18, 1862-1869 (2004)Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council
This publication has 28 references indexed in Scilit:
- Mechanisms of resistance to antibiotics.Current Opinion in Chemical Biology, 2003
- Treatment of drug-resistant pneumococcal pneumoniaThe Lancet Infectious Diseases, 2002
- Recent advances in the formation of the bacterial peptidoglycan monomer unit (1985 to 2000)Natural Product Reports, 2001
- Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide AntibioticScience, 1999
- Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibioticsMolecular Microbiology, 1998
- Methicillin-resistant Staphylococus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilitiesThe Lancet, 1997
- Applications of the bacteriocin, nisinAntonie van Leeuwenhoek, 1996
- THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUPAnnual Review of Microbiology, 1984
- Mechanism of Action of Bacitracin: Complexation with Metal Ion and C 55 -Isoprenyl PyrophosphateProceedings of the National Academy of Sciences, 1971
- Biosynthesis of the Peptidoglycan of Bacterial Cell WallsPublished by Elsevier ,1968